Hepatitis B seroprevalence in children and women and the impact of the hepatitis B vaccination program in the Black Sea region of Turkey

Journal of Infection in Developing Countries

Volumn 7, Issue 12, 2013, Pages 960-965

  Karatekin, Güner ^a   Kilinç, Mehmet ^b   Öksüz, Banu Gülcan ^c   Iǧde, Mahir ^c  

^a Zeynep Kamil Maternity and Child Research and Training Hospital   (Turkey)

^b Samsun Maternity and Child Health Hospital   (Turkey)

^c Samsun Education and Research Hospital   (Turkey)

Author keywords

Children; Hepatitis B; Seroprevalence; Vaccination; Women

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE POLICY; HEPATITIS B; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEWBORN; RETROSPECTIVE STUDY; SEROPREVALENCE; TURKEY (REPUBLIC); VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; TURKEY; YOUNG ADULT;

EID: 84890538305     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.4102     Document Type: Article

References (24)

1. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28: 112-125.
2. Oluyemi A, Odeghe E (2012) Facing the challenges of hepatitis B management in a developing country. J Infect Dev Ctries 6: 299-300.
3. World Health Organization (2012) Hepatitis B fact sheet. No 204 (revised July 2012). Geneva: World Health Organization, 2012.
4. Centers for Disease Control and Prevention (2010) Viral Hepatitis Statistics and Surveillance United States, 2010. http://www.cdc.gov/hepatitis/Statistics/2010Surveillance (December 08, 2013)
5. European Centre for Disease Prevention and Control (ECDC) (2010). Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies. Technical Reports 14 Sep 2010. http://ecdc.europa.eu/en/publications/Publications/TER_100914_Hep_B_C%20_EU_neighbourhood.pdf (December 08, 2013)
6. Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E, Spada E, National Surveillance System for Acute Viral Hepatitis (SEIEVA) Collaborating Group (2008) Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis 15: 868-875.
7. Zacharakis G, Kotsiou S, Papoutselis M, Vafiadis N, Tzara F, Pouliou E, Maltezos E, Koskinas J, Papoutselis K (2009) Changes in the epidemiology of hepatitis B virus infection following the implementation of immunisation programmes in northeastern Greece. Euro Surveill 13 pii: 19297.
8. Türk Karaciǧer Araşti{dotless}rmalari{dotless} Derneǧi Ulusal Hepatit Si{dotless}kli{dotless}ǧi{dotless} Çali{dotless}şmasi{dotless} (TÜRKHEP 2010), Turkey Liver Research Association, The National Study of Prevalence of Hepatitis http://www.tasl.org.tr/dosya/tasl_Ulusal_Hepatit_sikligi_Calismasi.pdf (December 08, 2013)
9. Cetinkaya F, Gürses N, Oztürk F (1995) Hepatitis B seroprevalence among children in a Turkish hospital. J Hosp Infect 29: 217-219.
10. Iarovoi P, Rimis C, Spinu C, Isac M (2008) Epidemiology of hepatitis B virus infection in the Republic of Moldova. J Infect Dev Ctries 2: 190-192.
11. Kanra G, Tezcan S, Badur S; Turkish National Study Team (2005) Hepatitis B and measles seroprevalence among Turkish children. Turk J Pediatr 47: 105-110.
12. Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, Paupunwatana S, Chaiear K, Khwanjaipanich S, Poovorawan Y (2006) Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 11: 1496-1502.
13. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28: 112-125.
14. Hsu HY, Chang MH, Ni YH, Chiang CL, Chen HL, Wu JF, Chen PJ (2010) No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J Infect Dis 15: 1192-1200.
15. Sidal M, Unüvar E, Oǧuz F, Cihan C, Onel D, Badur S (2001) Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey. Eur J Epidemiol 17: 141-144.
16. Kangin M, Turhanoglu M, Gulsun S, Cakabay B (2010) Seroprevalence of Hepatitis B and C among Children in Endemic Areas of Turkey. Hepat Mon 10: 36-41.
17. Zhang Y, Fang W, Fan L, Gao X, Guo Y, Huang W, Du Y (2013) Hepatitis B surface antigen prevalence among 12,393 rural women of childbearing age in Hainan Province, China: a cross-sectional study. Virol J 10: 25.
18. Mahamat A, Louvel D, Vaz T, Demar M, Nacher M, Djossou F (2010) Short Report High Prevalence of HBsAg during Pregnancy in Asian Communities at Cayenne Hospital, French Guiana. Am J Trop Med Hyg 10: 711-713.
19. Batham A, Narula D, Toteja T, Sreenivas V, Puliyel JM (2007) Sytematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatr 44: 663-674.
20. Bertolini DA, Pinho JR, Saraceni CP, Moreira RC, Granato CF, Carrilho FJ (2006) Prevalence of serological markers of hepatitis B virus in pregnant women from Paraná State, Brazil. Braz J Med Biol Res 39: 1083-1090.
21. Kolawole OM, Wahab AA, Adekanle DA, Sibanda T, Okoh AI (2012) Seroprevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria. Virol J 9: 317.
22. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, Radmard AR, Zaer-Rezaii H, Zeid-Abadi-Nejhad M, Hosseini MR, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R (2009) The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med 12: 225-231.
23. Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer O, Zeynep S (2005) Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas. Jpn J Infect Dis 58: 15-19.
24. Toy M, Önder FO, Wörmann T, Bozdayi AM, Schalm SW, Borsboom GJ, van Rosmalen J, Richardus JH, Yurdaydin C (2011) Age-and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis 11: 337.